Expression systems of cytochrome P450 proteins in studies of drug metabolism in vitro

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2011, Vol 65, Issue 0

Abstract

Cytochrome P450 proteins are the most important enzymes involved in metabolic activation or detoxification of various drugs used in clinical practice. However, some drug metabolism pathways may be responsible for their increased toxicity. New expression systems of cytochrome P450 proteins in mammalian cells, including human, are designed to explore the influence of metabolism on the cellular and molecular mechanisms of action of potential drugs and those used therapeutically. They can also be used to study the effect of tested compounds on activity and expression of metabolizing enzymes. Human tumor cell lines with overexpression of cytochrome P450 isoenzymes are of particular importance, especially in studies of potential chemotherapeutics. The HepG2 cell line, derived from human liver cancer, is the most commonly used in studies on drug metabolism and toxicity. However, due to the low level of metabolizing enzymes in these cells, the Hep3A4 cell line with overexpression of CYP3A4 isoenzyme was developed. The stable overexpression of cytochrome P450 isoenzymes was also obtained in other human cancer cell lines, including hepatoma HepaRG cells, ovarian cancer IGROV-1 cells, colon cancer Caco-2, and LS180 cells. This review describes currently developed bacterial, yeast, insect and mammalian (including human) cytochrome P450 protein expression systems, in terms of their advantages and disadvantages in the context of their suitability for basic research and use on a commercial scale.

Authors and Affiliations

Monika Pawłowska, Ewa Augustin

Keywords

Related Articles

Long-term use of estrogens: benefit or risk

Estrogens are widely used in hormone replacement therapy, gynecology, urogynecology and rarely in dermatology. Non-therapeutic use of estrogens is very widespread. Estrogens are used as contraceptives, which cause a lot...

Ibudilast: nieselektywny inhibitor fosfodiesterazy w chorobach ośrodkowego układu nerwowego

Ibudilast (IBD) jest niewybiórczym inhibitorem fosfodiesterazy (PDE) typu 3, 4, 10, 11, stosowanym głównie jako lek bronchodilatacyjny w leczeniu chorych z astmą. PDE uczestnicząc w metabolizmie cyklicznych nukleotydów,...

Autofagia i białko BNIP3 w nowotworach

Autofagia jest procesem niezbędnym do utrzymania homeostazy komórek w warunkach fizjologicznych, a także pod wpływem czynników stresowych, np. niedoboru składników odżywczych lub tlenu. Autofagia odgrywa także istotną ro...

Zaburzenia tolerancji węglowodanowej w trakcie leczenia glikokortykosteroidami u chorych na zapalne schorzenia układu ruchu – na podstawie analizy danych z piśmiennictwa oraz wyników badań własnych

Glikokortykosteroidy są jednymi z najczęściej stosowanych leków przeciwzapalnych i immunosupresyjnych. Są stosowane w terapii wielu schorzeń o podłożu autoimmunizacyjnym. Leczenie wiąże się jednak z ryzykiem wystąpienia...

Download PDF file
  • EP ID EP66490
  • DOI -
  • Views 143
  • Downloads 0

How To Cite

Monika Pawłowska, Ewa Augustin (2011). Expression systems of cytochrome P450 proteins in studies of drug metabolism in vitro. Advances in Hygiene and Experimental Medicine, 65(0), 367-376. https://europub.co.uk/articles/-A-66490